Legend Biotech

Our team had a great time at the American Society of Clinical Oncology (ASCO)’s Annual Meeting. Thank you to everyone who stopped by our exhibit and joined us as we shared our latest #MultipleMyeloma data.     It is always an honor to connect with fellow oncology leaders who share our goal of improving the lives of patients worldwide.    #CellTherapy #CART #ASCO24 

Our CEO, Ying Huang, will participate in a fireside chat at the Jefferies Healthcare Conference tomorrow, June 6, at 10:30 a.m. ET.   Don’t forget to register for the fireside chat: https://lnkd.in/ejeWxZQt   #JefferiesHealthcare

At this year’s American Society of Clinical Oncology (ASCO) Annual Meeting, we are excited to present new data from our groundbreaking #MultipleMyeloma studies.    We are rapidly advancing our CAR-T cell program to meet the unmet needs of patients battling this incurable disease.     Click here to read about our latest results: https://bwnews.pr/3VreH24    #CellTherapy #CART #ASCO24 

This #NationalCancerSurvivorDay, we honor the strength and resilience of all cancer survivors. Their determination inspires us daily as we work to bring new hope to #MultipleMyeloma patients and strive to develop a cure. Learn more about our research and development efforts: https://lnkd.in/eNs5VmNJ                                                               #Oncology #NCSD2024

Mark your calendars! Our CEO, Ying Huang, will participate in a fireside chat at the #JefferiesHealthcare Conference on June 6 at 10:30 a.m. ET. Learn more about the session and register: https://lnkd.in/eQWgetpT #CellTherapy #CART

Our passion to support the #BloodCancer community is at the core of our work. Here are three ways we are working to address barriers to treatment to improve patients’ lives.     Learn more about our patient-focused approach in our ESG report: https://lnkd.in/eZ-PxPWZ     #WorldBloodCancerDay   #CellTherapy 

We are looking forward to attending the American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA)’s Annual Meetings to showcase our unique expertise in #CellTherapy development by presenting our latest research in #MultipleMyeloma treatment.    By driving innovation in multiple myeloma therapy, we remain resolute in our commitment to providing patients with more advanced treatment options.     Learn more about our upcoming presentations and stop by our ASCO exhibit #12131: https://bwnews.pr/3R09Fa5  #ASCO24 #EHA2024 

⏳ Last Chance to Register for the EP PerMed Round Table 2024! Registration closes tomorrow! Don't miss out on your chance to be part of this pivotal event in Personalised Medicine (PM) on 27 May. 🌟 Join an exceptional lineup of speakers and panellists, including: - Jerome Van Biervliet (VIB) - Ejner Knud Moltzen (ICPerMed - The International Consortium for Personalised Medicine ) - Experts from King Baudouin Foundation, Biocat, BioRegion of Catalonia, UZ Gent, Bioxodes, MEDVIA, BBMRI-ERIC, Legend Biotech and Sciensano. Event Details: 🗓 Date: 27 May 2024 ⏰ Time: Starts at 16:00 📍 Venue: EIT House, Brussels, Belgium 🔗 Secure your spot now and be part of the conversations that will shape the future of healthcare. Register here: https://lnkd.in/eG765wf4 💡 Can't make it to Brussels? Join us online and be part of the event virtually. Just save this meeting link and dial in on 27 May at 16 hrs. https://lnkd.in/e4bxYD4n The EP PerMed Round Table is a side event of ‘The convergence of technologies enabling R&I for the healthcare of the future’, organised under the Belgian presidency of the Council of European Union. Let's revolutionize healthcare together! 💪 #EPPerMed #HealthcareInnovation #PersonalisedMedicine Sofie Bekaert, Montse Daban Marín, Elfride De Baere, Marc Dechamps, Isabelle Francois, Jens K. Habermann, Pieter Jacobs, Marc Van den Bulcke, Bart Haex, Merike Leego, Kathleen D'Hondt, Jolien Roovers, EP PerMed - the European Partnership for Personalised Medicine, Belgian Presidency of the Council of the European Union 2024, EIT Health

Today, VIB received an international delegation on a roadtrip through the Flemish life sciences cluster. On the program: 💡Keynote on the Flemish biotech ecosystem by our Managing Director, Jerome Van Biervliet 💡An inspirational talk on VIB Technologies by Sofie Coelus 💡Annemarie Van Nieuwenhuijze of Sanofi Belgium on the Nanobody legacy 💡Jasper Van Hoorick of BIO INX on the potential of 3D bioprinting 💡Frederik Buysse of Legend Biotech on what it takes to establish a CAR-T facility in less than 3 years 💡Sam Possemiers of MRM Health on their activities in microbiology research. Thanks to flanders.bio and Flanders Investment & Trade (FIT) for bringing the rest of the world a little bit closer to Flanders. 💪

Members of our Legend team in Belgium recently participated in Kom op tegen Kanker’s cycling challenge benefitting cancer research. Our LEGENDs trained hard to cycle 1000km from May 9-12. Their determination and passion for giving back to the oncology community has inspired us all. Congratulations to the team for this incredible feat! #WeAreLegend #KomOpTegenKanker #de1000km